OMAHA – The University of Nebraska Medical Center has launched a major clinical research study with the goal of finding a way to detect pancreatic cancer in its earliest stage.
The study is being funded by a grant from the National Cancer Institute and is being led by UNMC’S Doctor Kelsey Klute.
Doctors are seeking to enroll up to 1,200 people.
Study subjects must be 19 years or older and have a history of pre or onset diabetes, chronic pancreatic or pancreatic cancer.
Participants will be seen at Nebraska Medicine every 6 months over the course of 5 years or more.
At each visit, they will be given a questionnaire and have their blood drawn.
Doctors with UNMC say a long term study like this doesn’t exist anywhere else.
